On September 14, 2017, Jingtian & Gongcheng’s WuXi Biologics US$ 510M IPO project won CLP 2017 Equity Deal of the Year.

Jingtian & Gongcheng is also cited for the following 12 awards:

1. Equity Deal of the Year: Meitu HK$ 4.9B IPO;

2. Capital Markets Firm of the Year;

3. Insurance Firm of the Year;

4. M&A Firm of the Year;

5. Private Equity & Venture Capital Firm of the Year;

6. Real Estate Firm of the Year;

7. Dealmaker of the Year – China: Hu Zhengzheng;

8. Dispute Resolution Lawyer of the Year: Dong Chungang;

9. Private Client Lawyer of the Year: Wu Wiyi;

10. Real Estate & Construction Lawyer of the Year: Fu Fusheng;

11. Regulatory & Compliance Lawyer of the Year: Sun Shiqi;

12. SSQ China Firm of the Year.

China Law & Practice is an authoritative legal media under world-renowned publishing house ALM Group. CLP Annual Awards are selected by China Law & Practice, Asian Lawyers, American Lawyers and the editing team of Legal Week through extensive client survey and expert appraisal. It has become one of the most recognized awards by China’s legal industry for is comprehensiveness, objectivity and strict standards.

The awards are recognition of the cooperation between Jingtian & Gongcheng and its clients. We thank our clients for their trust and support and will continue to provide quality legal services in the future.